A nicotine pouched product is disclosed, the nicotine pouched product having a pouch composition and a pouch membrane enclosing the pouch composition, the pouch composition including at least one water-insoluble fiber, water in an amount of at least 15% by weight of the composition, and nicotine, wherein the pouch membrane comprises further nicotine in an amount of at least 15% by weight of a total content of nicotine in the pouched product.

The invention relates to inclusion of one or more sugars or isolated sugars in a smoking article.

An exemplary smoking article including a smoking rod filled with a combination including tobacco filler material and cellulose filler material. The tobacco filler material and cellulose filler material can be arranged such that the constituent material particles are generally distributed throughout the smoking rod, the tobacco filler material at least partially surrounds the cellulose filler material along a length of the smoking rod, and/or the cellulose filler material particles have a higher concentration along a central axis of the smoking rod than the tobacco filler material particles.

A tobacco product reduces or mitigates some of the negative effects of tobacco consumption, particularly cancer development. The tobacco product contains (a) nicotine, (b) at least one of an isothiocyanate or isothiocyanate precursor, (c) myrosinase and (d) a synthetic isothiocyanate. The product can further include at least one of thymoquinone, resveratrol, synthetic vitamin C, thymoquinone resveratrol and a synthetic vitamin C.

A flavor inhaler includes a control unit configured to control operation of the flavor inhaler; a main switch electrically connected to an input side of the control unit, the main switch configured to send a signal to the control unit to start operation of the control unit; and a sub switch electrically connected to the control unit, the sub switch configured to send a signal to the control unit to start supplying liquid from a liquid holding unit accommodating an aerosol base.

There is provided a flavored vaporizable formulation comprising (i) one or more solvents; (ii) a flavor; and (iii) one or more cyclodextrins; wherein the flavored vaporizable formulation contains water in an amount of from 0 to 10 wt. % based on the vaporizable formulation.

A consumable for an aerosol provision system, a process for producing the consumable, as well as to an aerosol provision system including said consumable. The consumable includes at least one flavor glycoside, and aerosol-generating material, wherein the consumable has greater than about 15 wt. % water. Also disclosed are various uses of the flavor glycoside.

A nicotine sheet and an aerosol-generating article including the same are provided. The nicotine sheet according to some embodiments of the present disclosure may include a nicotine material which includes a nicotine component and a cellulose-based material which forms a sheet. The nicotine sheet may, when heated, slowly release the nicotine component fixed therein and thus can improve persistence of a tobacco smoke taste of an aerosol-generating article.

The present disclosure relates to an oral pouched nicotine product comprising a moist filling material and a saliva-permeable pouch of a packaging material enclosing the moist filling material, wherein the moist filling material comprises a particulate non-tobacco material; a non-encapsulated non-particulate flavouring agent; a nicotine source; a pH adjusting agent; a monoglyceride; and tobacco material within the range of from 0% to % by weight, based on the total weight of the moist filling material.

A composition that includes vitamin A (e.g., retinol) and vitamin E (e.g., gamma-tocopherol), suitable for at least one of pulmonary administration, aerosolization, and intranasal administration. The composition can further include a pharmaceutically acceptable solid or liquid carrier. The composition can be in a unit dosage form or a metered dosage form and can be configured for pulmonary or intranasal administration. Also included are nutritional supplements, intranasal sprays, pulmonary sprays, pulmonary powders, cigarettes, and/or electronic cigarettes, each including the composition. Also included are methods of administering the composition to a human, e.g., within the oral cavity or within the respiratory system.